<DOC>
	<DOCNO>NCT03048149</DOCNO>
	<brief_summary>This study retrospective . It focus hazelnut allergic patient clinical history positive specific immunoglobulin E ( sIgE ) hazelnut recombinant follow hazelnut oral tolerance induction allergy Unit Saint Vincent Hospital Lille ( France ) since 2011 .</brief_summary>
	<brief_title>Clinical Biological Efficacy Hazelnut Oral Immunotherapy</brief_title>
	<detailed_description>Prevalence food allergy perpetual progression since several year . It multiply three 10 15 year . Hazelnut allergy lead severe anaphylactic shock , particularly child . It long lasting condition le 10 % natural healing . Increasing threshold reactive dose hazelnut patient , i.e . minimal dose hazelnut trigger allergic reaction , primary importance allow avoid severe anaphylactic reaction happen even consumption low allergen dos . Those reaction occur even elimination diet . This increase also allow reintegration patient community , beneficial impact quality life . The increase threshold reactive dose possible introduction oral tolerance induction ( OTI ) protocol . It consist regular consumption low control dos hazelnuts progressively increase . Thus protocol conduct allergy Unit Saint Vincent Hospital Lille ( France ) standard care since 2006 , data publish tree nut , especially France . Most data peanut , although consumption tree nut high France . For OTI protocol , oral food challenge ( OFC ) perform . This OFC allow determination threshold reactive dose , i.e . minimum dose allergen induces allergic reaction . A safe dose hazelnut regularly eaten patient determine . Every 6 month , new OFC perform thus new threshold reactive dose measure , dose eaten patient update . The protocol follow patient reach ideal dose 11766 mg hazelnut protein . Of course , protocol also end patient decide . The main objective study study clinical efficiency hazelnut OTI measure evolution patient threshold reactive dose . The secondary objective study biological efficiency hazelnut OTI measure evolution dosage sIgE hazelnut proteins evolution size prick test . As OFC IgE dosage standard part OTI protocol , data obtain medical record . The study retrospective thus observational .</detailed_description>
	<criteria>Patients clinical symptom consume hazelnut , urticaria , asthma , angioedema , atopic dermatitis , dermorespiratory syndrome anaphylactic shock . Positive sIgE hazelnut , r Cor 1 , 8 , 9 14 Patients follow hazelnut oral tolerance induction No clinical symptom biological confirmation hazelnut allergy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hazelnut allergy</keyword>
</DOC>